Enhancement tumor-associated antigen expression hormone-related ovarian serous borderline tumors immunoreactivity monoclonal antibody MoAb ovarian serous tumors borderline malignancy women pregnant hormone medication progestin secretory phase menstrual cycle similar tumors patients categories borderline tumors tumor-associated glycoprotein MoAb differences hormone-related nonhormone-related tumors Differences staining tumors pregnant patients previous persistent recurrent tumors ipsilateral contralateral ovaries patients pregnant Tumor MoAb reactivity progressive gestational age levels term postpartum period cell culture studies expression human tumors hormonal stimulation 